Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Hong Kong · Delayed Price · Currency is HKD

47.50

-0.80 (-1.66%)

Sep 11, 2026, 4:08 PM HKT

HKG:6609 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	513.79	408.29	277.9	232.34	183.03	90.09
Revenue Growth	25.84%	46.92%	19.61%	26.94%	103.17%	518.66%
Gross Profit	353.55	272.17	173.66	151.79	123.88	54.95
Operating Income	89.56	44.27	-33.34	-126.87	-199.62	-159.58
Net Income	92.76	83.34	-13.62	-94.01	-200.38	-194.23
Earnings Per Share	2.47	2.20	-0.36	-2.47	-5.24	-5.82
EPS Growth	12.13%	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	494.51	391.38	269.5	231.27	182.91	90.06
Others	19.28	16.9	8.4	1.07	0.12	0.03
Total	513.79	408.29	277.9	232.34	183.03	90.09

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	789.7	786.48	713.72	721.14	870.12	1,218
Total Debt	41.22	42.72	35.75	36.38	50.69	41.94
Net Cash (Debt)	748.49	743.76	677.97	684.76	819.44	1,176
Net Cash Growth	0.64%	9.70%	-0.99%	-16.44%	-30.31%	93.47%
Net Cash Per Share	19.90	19.60	17.95	17.98	21.41	35.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	154.14	-3.23	-88.41	-266.77	-205.85
Capital Expenditures	-	-11.59	-4.04	-4.58	-36.51	-52.83
Free Cash Flow	-	142.55	-7.27	-92.98	-303.28	-258.69
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.81%	66.66%	62.49%	65.33%	67.68%	60.99%
Operating Margin	17.43%	10.84%	-12.00%	-54.60%	-109.06%	-177.13%
Pretax Margin	21.47%	21.16%	-4.32%	-44.30%	-109.95%	-219.68%
Profit Margin	18.05%	20.41%	-4.90%	-40.46%	-109.48%	-215.59%
FCF Margin	-	34.91%	-2.62%	-40.02%	-165.70%	-287.14%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.68	22.12	-	-	-	-
Forward PE	-	33.00	29.68	-	-	-
P/FCF Ratio	-	12.93	-	-	-	-
PS Ratio	3.03	4.51	2.83	4.43	6.85	36.80